Regulation of cancer-related gene expression by galectin-3 and the molecular mechanism of its nuclear import pathway

Cancer and Metastasis Reviews

Volumn 26, Issue 3-4, 2007, Pages 605-610

  Nakahara, Susumu ^a,b   Raz, Avraham ^a  

^a WAYNE STATE UNIVERSITY   (United States)

^b Suita Municipal Hospital   (Japan)

Author keywords

Galectin 3; Gene expression; Nuclear import; Transcription factor

Indexed keywords

CRE RECOMBINASE; CYCLIN D1; GALECTIN 3; MUCIN 2; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR SP1;

ACTIVE TRANSPORT; AMINO TERMINAL SEQUENCE; BINDING SITE; CANCER GROWTH; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; CELL GROWTH; CELL NUCLEUS; COMPLEX FORMATION; DNA PROTEIN COMPLEX; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; NUCLEAR IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; ONCOGENE; PASSIVE TRANSPORT; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEPHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REVIEW;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CYCLIN D1; DNA-BINDING PROTEINS; GALECTIN 3; GENE EXPRESSION REGULATION; HUMANS; MUCINS; NEOPLASMS; PHOSPHORYLATION; PROTEIN TRANSPORT;

EID: 36148941318     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-007-9095-6     Document Type: Review

References (44)

1. Barondes, S. H., Castronovo, V., Cooper, D. N., Cummings, R. D., Drickamer, K., Feizi, T., et al. (1994). Galectins: A family of animal beta-galactoside-binding lectins. Cell, 76, 597-598.
2. Liu, F. T., & Rabinovich, G. A. (2005). Galectins as modulators of tumour progression. Nature Reviews Cancer, 5, 29-41.
3. Hirabayashi, J., Hashidate, T., Arata, Y., Nishi, N., Nakamura, T, Hirashima M., et al. (2002). Oligosaccharide specificity of galectins: A search by frontal affinity chromatography. Biochimica et Biophysica Acta, 1572, 232-254.
4. Ochieng, J., Furtak, V., & Lukyanov, P. (2004). Extracellular functions of galectin-3. Glycoconjugate Journal, 19, 527-535.
5. Nakahara, S., Oka, N., & Raz, A. (2005). On the role of galectin-3 in cancer apoptosis. Apoptosis, 10, 267-275.
6. Park, J. W., Voss, P. G., Grabski, S., Wang, J. L., & Patterson, R. J. (2001). Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein. Nucleic Acids Research, 29, 3595-3602.
7. Wang, J. L., Gray, R. M., Haudek, K. C., & Patterson, R. J. (2004). Nucleocytoplasmic lectins. Biochimica et Biophysica Acta, 1673, 75-93.
8. Paces-Fessy, M., Boucher, D., Petit, E., Paute-Briand, S., & Blanchet-Tournier, M. F. (2004). The negative regulator of Gli, Suppressor of fused (Sufu), interacts with SAP18, Galectin3 and other nuclear proteins. Biochemical Journal, 378, 353-362.
9. Lin, H. M., Pestell, R. G., Raz, A., & Kim, H. R. (2002). Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene, 21, 8001-8010.
10. Paron, I., Scaloni, A., Pines, A., Bachi, A., Liu, F. T., Puppin, C., et al. (2003). Nuclear localization of Galectin-3 in transformed thyroid cells: A role in transcriptional regulation. Biochemical and Biophysical Research Communications, 302, 545-553.
11. Song, S., Byrd, J. C., Mazurek, N., Liu, K., Koo, J. S., & Bresalier, R. S. (2005). Galectin-3 modulates MUC2 mucin expression in human colon cancer cells at the level of transcription via AP-1 activation. Gastroenterology, 129, 1581-1591.
12. Pieters, R. J. (2006). Inhibition and detection of galectins. Chembiochem, 7, 721-728.
13. Nakahara, S., Oka, N., Wang, Y., Hogan, V., Inohara, H., & Raz, A. (2006). Characterization of the nuclear import pathways of galectin-3. Cancer Research, 66, 9995-10006.
14. Nakahara, S., Hogan, V., Inohara, H., & Raz, A. (2006). Importin-mediated nuclear translocation of galectin-3. Journal of Biological Chemistry, 281, 39649-39659.
15. Moutsatsos, I. K., Davis, J. M., & Wang, J. L. (1986). Endogenous lectins from cultured cells: subcellular localization of carbohydrate-binding protein 35 in 3T3 fibroblasts. Journal of Cell Biology, 102, 477-483.
16. Moutsatsos, I. K., Wade, M., Schindler, M., & Wang, J. L. (1987). Endogenous lectins from cultured cells: Nuclear localization of carbohydrate-binding protein 35 in proliferating 3T3 fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 84, 6452-6456.
17. Dagher, S. F., Wang, J. L., & Patterson, R. J. (1995). Identification of galectin-3 as a factor in pre-mRNA splicing. Proceedings of the National Academy of Sciences of the United States of America, 92, 1213-1217.
18. Patterson, R. J., Wang, W., & Wang, J. L. (2004). Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconjugate Journal, 19, 499-506.
19. Lotz, M. M., Andrews Jr., C. W., Korzelius, C. A., Lee, E. C., Steele Jr., G. D., Clarke, A., et. al. (1993). Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma. Proceedings of the National Academy of Sciences of the United States of America, 90, 3466-3470.
20. Honjo, Y., Inohara, H., Akahani, S., Yoshii, T., Takenaka, Y., Yoshida, J., et. al. (2000). Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clinical Cancer Research, 6, 4635-4640.
21. Mathieu, A., Saal, I., Vuckovic, A., Ransy, V., Vereerstraten, P., Kaltner, H., et al. (2005). Nuclear galectin-3 expression is an independent predictive factor of recurrence for adenocarcinoma and squamous cell carcinoma of the lung. Modern Pathology, 18, 1264-1271.
22. Kim, H. R., Lin, H. M., Biliran, H., & Raz, A. (1999). Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells. Cancer Research, 59, 4148-4154.
23. Takenaka, Y., Inohara, H., Yoshii, T., Oshima, K., Nakahara, S., Akahani, S., et al. (2003). Malignant transformation of thyroid follicular cells by galectin-3. Cancer Letter, 195, 111-119.
24. Bresalier, R. S., Byrd, J. C., Wang, L., & Raz, A. (1996). Colon cancer mucin: A new ligand for the beta-galactoside-binding protein galectin-3. Cancer Research, 56, 4354-4357.
25. Huflejt, M. E., Turck, C. W., Lindstedt, R., Barondes, S. H., & Leffler, H. (1993). L-29, a soluble lactose-binding lectin, is phosphorylated on serine 6 and serine 12 in vivo and by casein kinase I. Journal of Biological Chemistry, 268, 26712-26718.
26. Mazurek, N., Conklin, J., Byrd, J. C., Raz, A., & Bresalier, R. S.(2000). Phosphorylation of the beta-galactoside-binding protein galectin-3 modulates binding to its ligands. Journal of Biological Chemistry, 275, 36311-36315.
27. Tsay, Y. G., Lin, N. Y., Voss, P. G., Patterson, R. J., Wang, J. L. (1999). Export of galectin-3 from nuclei of digitonin-permeabilized mouse 3T3 fibroblasts. Experimental Cell Research, 252(2), 250-261.
28. Yoshii, T., Fukumori, T., Honjo, Y., Inohara, H., Kim, H. R., Raz, A. (2002). Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. Journal of Biological Chemistry, 277, 6852-6857.
29. Mazurek, N., Sun, Y. J., Price, J. E., Ramdas, L., Schober, W., Nangia-Makker, P., et al. (2005). Phosphorylation of galectin-3 contributes to malignant transformation of human epithelial cells via modulation of unique sets of genes. Cancer Research, 65(23), 10767-10775.
30. Gorlich, D., & Mattaj, I. W. (1996). Nucleocytoplasmic transport. Science, 271, 1513-1518.
31. Pante, N., & Aebi, U. (1996). Sequential binding of import ligands to distinct nucleopore regions during their nuclear import. Science, 273, 1729-1732.
32. Gong, H. C., Honjo, Y., Nangia-Makker, P., Hogan, V., Mazurak, N., Bresalier, R. S., et al. (1999). The NH2 terminus of galectin-3 governs cellular compartmentalization and functions in cancer cells. Cancer Research, 59, 6239-6245.
33. Gaudin, J. C., Mehul, B., & Hughes, R. C. (2000). Nuclear localisation of wild type and mutant galectin-3 in transfected cells. Biology of the Cell, 92, 49-58.
34. Davidson, P. J., Li, S. Y., Lohse, A. G., Vandergaast, R., Verde, E., Pearson, A., et al. (2006). Transport of galectin-3 between the nucleus and cytoplasm. I. Conditions and signals for nuclear import. Glycobiology, 16(7), 602-611.
35. Davidson, P. J., Davis, M. J., Patterson, R. J., Ripoche, M. A., Poirier, F., & Wang, J. L. (2002). Shuttling of galectin-3 between the nucleus and cytoplasm. Glycobiology, 12, 329-337.
36. Adam, S. A., & Gerace, L. (1991). Cytosolic proteins that specifically bind nuclear location signals are receptors for nuclear import. Cell, 66, 837-847.
37. Imamoto, N., Shimamoto, T., Takao, T, Tachibana, T, Kose, S, Matsubae, M., et al. (1995) In vivo evidence for involvement of a 58 kDa component of nuclear pore-targeting complex in nuclear protein import. EMBO Journal, 14, 3617-3626.
38. Kose, S., Imamoto, N., Tachibana, T., Shimamoto, T., & Yoneda, Y. (1997). Ran-unassisted nuclear migration of a 97-kD component of nuclear pore-targeting complex. Journal of Cell Biology, 139, 841-849.
39. Yokoya, F., Imamoto, N., Tachibana, T., & Yoneda, Y. (1999). beta-catenin can be transported into the nucleus in a Ran-unassisted manner. Molecular Biology of the Cell, 10, 1119-1131.
40. Gorlich, D., & Kutay, U. (1999). Transport between the cell nucleus and the cytoplasm. Annual Review of Cell and Developmental Biology, 15, 607-660.
41. Allen, T. D., Cronshaw, J. M., Bagley, S., Kiseleva, E., & Goldberg, M. W. (2000). The nuclear pore complex: Mediator of translocation between nucleus and cytoplasm. Journal of Cell Science, 113(Pt 10), 1651-1659.
42. Yang, R. Y, Hill, P. N., Hsu, D. K., & Liu, F. T. (1998). Role of the carboxyl-terminal lectin domain in self-association of galectin-3. Biochemistry, 37, 4086-4092.
43. Ahmad, N., Gabius, H. J., Andre, S., Kaltner, H., Sabesan, S, Roy, R., et al. (2004). Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. Journal of Biological Chemistry, 279, 10841-10847.
44. Nangia-Makker, P., Hogan, V., Honjo, Y., Baccarini, S., Tait, L., Bresalier, R., et al. (2002). Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. Journal of the National Cancer Institute, 94, 1854-1862.